← Leaderboards
Bruce L. Zuraw
Va San Diego Healthcare System
$6,604,515
Attributed
$6,609,515
Total exposure
28
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$12,265,817 · 27
VA$0 · 2
By mechanism
P01$5,656,302 · 3
U19$3,288,342 · 3
R01$3,078,535 · 3
M01$232,638 · 17
R13$10,000 · 1
I01$0 · 2
Top collaborators
- Aleena S Banerji1 shared
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectInflammationAsthmaClinical ResearchHereditary Angioneurotic EdemaMediatingResponseProteinsAnti-InflammatoryEpithelial CellsRespiratory EpitheliumAirway InflammationAcuteAnti-Inflammatory AgentsPhenotypePreventRhinovirusAirway RemodelingStimulusAllergic Airway InflammationLungAllergensIn VivoPredisposition
Grant awards (60)
Mechanisms Underlying the Dominant Negative Phenotype in Hereditary Angioedema$0
I01 · FY2023 · VA · contact PI
Mechanisms Underlying the Dominant Negative Phenotype in Hereditary Angioedema$0
I01 · FY2022 · VA · contact PI
Mechanisms Underlying the Dominant Negative Phenotype in Hereditary Angioedema$0
I01 · FY2021 · VA · contact PI
Mechanisms Underlying the Dominant Negative Phenotype in Hereditary Angioedema$0
I01 · FY2020 · VA · contact PI
Epithelial GILZ in Inflammation and Remodeling$350,113
U19 · FY2015 · AI · contact PI
Epithelial GILZ in Inflammation and Remodeling$358,742
U19 · FY2014 · AI · contact PI
Hereditary Angioedema(HAE)Conference$10,000
R13 · FY2014 · AI · contact PI
Dual role of the bradykinin B2 receptor during inflammation$0
I01 · FY2014 · VA · contact PI
Epithelial GILZ in Inflammation and Remodeling$355,653
U19 · FY2013 · AI · contact PI
Dual role of the bradykinin B2 receptor during inflammation$0
I01 · FY2013 · VA · contact PI
Epithelial GILZ in Inflammation and Remodeling$354,245
U19 · FY2012 · AI · contact PI
Dual role of the bradykinin B2 receptor during inflammation$0
I01 · FY2012 · VA · contact PI
Epithelial GILZ in Inflammation and Remodeling$368,261
U19 · FY2011 · AI · contact PI
Dual role of the bradykinin B2 receptor during inflammation$0
I01 · FY2011 · VA · contact PI
Mechanisms and control of epithelial to mesenchymal transition in chronic asthma$288,421
U19 · FY2010 · AI · contact PI
CLINICAL TRIAL: PHASE II STUDY OF THE SAFETY & EFFICACY OF RECOMBINANT HUMAN C1$863
M01 · FY2010 · RR · contact PI
Mechanisms and control of epithelial to mesenchymal transition in chronic asthma$282,850
U19 · FY2009 · AI · contact PI
CLINICAL TRIAL: PHASE II STUDY OF THE SAFETY & EFFICACY OF RECOMBINANT HUMAN C1$566
M01 · FY2009 · RR · contact PI
GILZ Controls TLR-Induced NF-kB Activity In Acute Asthma$432,628
R01 · FY2008 · AI · contact PI
Mechanisms and control of epithelial to mesenchymal transition in chronic asthma$274,614
U19 · FY2008 · AI · contact PI
CLINICAL TRIAL: PHARMACOKINETICS OF C1INH-NF IN HEREDITARY ANGIOEDEMA SUBJECTS$5,038
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: PHASE II STUDY OF THE SAFETY & EFFICACY OF RECOMBINANT HUMAN C1$3,205
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: INVESTIGATE THE EFFICACY & SAFETY OF PURIFIED C1 ESTERASE INHIBI$2,290
M01 · FY2008 · RR · contact PI
GILZ Controls TLR-Induced NF-kB Activity In Acute Asthma$457,732
R01 · FY2007 · AI · contact PI
Mechanisms and control of epithelial to mesenchymal transition in chronic asthma$267,925
U19 · FY2007 · AI · contact PI
INVESTIGATE THE EFFICACY & SAFETY OF PURIFIED C1 ESTERASE INHIBITOR FOR HAE$10,078
M01 · FY2007 · RR · contact PI
GILZ Controls TLR-Induced NF-kB Activity In Acute Asthma$471,403
R01 · FY2006 · AI · contact PI
Mechanisms and control of epithelial to mesenchymal transition in chronic asthma$261,849
U19 · FY2006 · AI · contact PI
INITIATION AND PROPAGATION OF ASTHMATIC INFLAMMATION$1,101,516
P01 · FY2005 · AI
GILZ Controls TLR-Induced NF-kB Activity In Acute Asthma$419,770
R01 · FY2005 · AI
INITIATION AND PROPAGATION OF ASTHMATIC INFLAMMATION$791,346
P01 · FY2004 · AI
INITIATION AND PROPAGATION OF ASTHMATIC INFLAMMATION$392,813
P01 · FY2004 · AI
Disease variables in hereditary angioedema$64,603
M01 · FY2004 · RR
Anti-inflammatory effects of leukotriene antagonists$39,118
M01 · FY2004 · RR
Efficacy and tolerability of DX-88 for acute angioedema$31,413
M01 · FY2004 · RR
Signaling in allergic inflammation: Kinins, signaling and asthma$8,890
M01 · FY2004 · RR
Rhinovirus-mediated transcription in airway inflammation$7,704
M01 · FY2004 · RR
Initiation and propagation of asthmatic inflammation$4,148
M01 · FY2004 · RR
INITIATION AND PROPAGATION OF ASTHMATIC INFLAMMATION$1,152,201
P01 · FY2003 · AI
INITIATION AND PROPAGATION OF ASTHMATIC INFLAMMATION$1,042,315
P01 · FY2002 · AI
RHINOVIRUS MEDIATED TRANSCRIPTION IN AIRWAY INFLAMMATION$355,619
R01 · FY2002 · HL
DISEASE VARIABLES IN HEREDITARY ANGIOEDEMA$0
M01 · FY2002 · RR
CORE--CLINICAL$0
P01 · FY2002 · AI
KININ INDUCED CHEMOKINE EXPRESSION: MECHANISMS IN ASTHMA$0
P01 · FY2002 · AI
C1 INHIBITOR VAPOR HEATED IMMUNO IN HEREDITARY ANGIOEDEM$0
M01 · FY2002 · RR
SIGNALING IN ALLERGIC INFLAMMATION--KININS AND ASTHMA$0
M01 · FY2002 · RR
RHINOVIRUS MEDIATED TRANSCRIPTION IN AIRWAY INFLAMMATION$0
M01 · FY2002 · RR
COMPLEMENT AND HAGEMAN FACTOR IN ANGIOEDEMA$0
M01 · FY2002 · RR
INITIATION AND PROPAGATION OF ASTHMATIC INFLAMMATION$1,176,111
P01 · FY2001 · AI
RHINOVIRUS MEDIATED TRANSCRIPTION IN AIRWAY INFLAMMATION$350,961
R01 · FY2001 · HL
KININ INDUCED CHEMOKINE EXPRESSION: MECHANISMS IN ASTHMA$0
P01 · FY2001 · AI
CORE--CLINICAL$0
P01 · FY2001 · AI
RHINOVIRUS MEDIATED TRANSCRIPTION IN AIRWAY INFLAMMATION$330,193
R01 · FY2000 · HL
DISEASE VARIABLES IN HEREDITARY ANGIOEDEMA$260,229
R01 · FY2000 · AI
KININS, SIGNALING AND ASTHMA$125,669
U19 · FY2000 · AI
RHINOVIRUS MEDIATED TRANSCRIPTION IN AIRWAY INFLAMMATION$27,361
M01 · FY2000 · RR
COMPLEMENT AND HAGEMAN FACTOR IN ANGIOEDEMA$27,361
M01 · FY2000 · RR
DISEASE VARIABLES IN HEREDITARY ANGIOEDEMA$0
M01 · FY2000 · RR
C1 INHIBITOR VAPOR HEATED IMMUNO IN HEREDITARY ANGIOEDEM$0
M01 · FY2000 · RR
SIGNALING IN ALLERGIC INFLAMMATION--KININS AND ASTHMA$0
M01 · FY2000 · RR